Key references: Other therapies for functional dyspepsia
- Koletzko L, Macke L, Schulz C, Malfertheiner P. Helicobacter pylori eradication in dyspepsia: New evidence for symptomatic benefit. Best Pract Res Clin Gastroenterol 2019;40-41:101637. https://www.ncbi.nlm.nih.gov/pubmed/31594649
- Therapeutic Goods Administration. Medicines safety update. Ondansetron and QTc interval prolongation - dosing change. Aust Prescr 2012;35(6):198-9. https://www.nps.org.au/australian-prescriber/articles/medicines-safety-update-10
- von Arnim U, Peitz U, Vinson B, Gundermann KJ, Malfertheiner P. STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study. Am J Gastroenterol 2007;102(6):1268-75. https://www.ncbi.nlm.nih.gov/pubmed/17531013